Evidence map›Paper›PMID 23172143›Full record

ArticleNature2012

An alternative route to cyclic terpenes by reductive cyclization in iridoid biosynthesis.

Fernando Geu-Flores, Nathaniel H Sherden, Vincent Courdavault, Vincent Burlat, Weslee S Glenn, Cen Wu, Ezekiel Nims, Yuehua Cui, Sarah E O'Connor

Abstract read
In one paragraph

Article in Nature, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 133 papers.

0numbers the graph read from it
0cells of the map it votes in
133citing papers in PubMed
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

133 citing papers in PubMed, 332 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Convergence and parallelism in the evolution of plant metabolism.Journal of integrative plant biology · 2026
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Single-cell metabolome and RNA-seq multiplexing on single plant cells.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

73 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

Fernando Geu-FloresDepartment of Biological Chemistry, John Innes Centre, Norwich NR4 7UH, UK.
Nathaniel H Sherden
Vincent Courdavault
Vincent Burlat
Weslee S Glenn
Cen Wu
Ezekiel Nims
Yuehua Cui
Sarah E O'Connor
John Innes Centre · GBMassachusetts Institute of Technology · USMichigan State University · USLaboratoire de Recherche en Sciences Végétales · FRUniversité de Tours · FRUniversity of East Anglia · GB

Funding

Early Steps in Alkaloid BiosynthesisR01GM074820 · NIGMS · UNIVERSITY OF EAST ANGLIA · PI O'CONNOR, SARAH E · 2007 to 2011
$1.5M
Biotechnology and Biological Sciences Research Council BB/J009091/1NIGMS NIH HHS GM074820NIGMS NIH HHS R01 GM074820
6 · The paper itself

Abstract

The iridoids comprise a large family of distinctive bicyclic monoterpenes that possess a wide range of pharmacological activities, including anticancer, anti-inflammatory, antifungal and antibacterial activities. Additionally, certain iridoids are used as sex pheromones in agriculturally important species of aphids, a fact that has underpinned innovative and integrated pest management strategies. To harness the biotechnological potential of this natural product class, the enzymes involved in the biosynthetic pathway must be elucidated. Here we report the discovery of iridoid synthase, a plant-derived enzyme that generates the iridoid ring scaffold, as evidenced by biochemical assays, gene silencing, co-expression analysis and localization studies. In contrast to all known monoterpene cyclases, which use geranyl diphosphate as substrate and invoke a cationic intermediate, iridoid synthase uses the linear monoterpene 10-oxogeranial as substrate and probably couples an initial NAD(P)H-dependent reduction step with a subsequent cyclization step via a Diels-Alder cycloaddition or a Michael addition. Our results illustrate how a short-chain reductase was recruited as cyclase for the production of iridoids in medicinal plants. Furthermore, we highlight the prospects of using unrelated reductases to generate artificial cyclic scaffolds. Beyond the recognition of an alternative biochemical mechanism for the biosynthesis of cyclic terpenes, we anticipate that our work will enable the large-scale heterologous production of iridoids in plants and microorganisms for agricultural and pharmaceutical applications.

Indexed as

BiocatalysisAspergillus fumigatusBiological ProductsCatharanthusCyclizationCycloaddition ReactionIridoidsMolecular Sequence DataMonoterpenesNADPOxidoreductasesPlant ExtractsPlant LeavesPlants, MedicinalSubstrate SpecificityBiological ProductsIridoidsMonoterpenesNADPOxidoreductasesPlant Extracts

Identifiers

PMID23172143
PMCPMC13215347
OpenAlexW2088338463

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.